Operating Lease, Liability, Noncurrent of Immunovant, Inc. from 31 Mar 2020 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Immunovant, Inc. quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 31 Mar 2020 to 31 Mar 2024.
  • Immunovant, Inc. Operating Lease, Liability, Noncurrent for the quarter ending 31 Mar 2024 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

Immunovant, Inc. Quarterly Operating Lease, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $0 -$47,000 -100% 31 Mar 2024 10-K 29 May 2024 2024 FY
Q4 2023 $0 -$306,000 -100% 31 Dec 2023 10-Q 12 Feb 2024 2024 Q3
Q3 2023 $0 -$614,000 -100% 30 Sep 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 $0 -$919,000 -100% 30 Jun 2023 10-Q 10 Aug 2023 2024 Q1
Q1 2023 $47,000 -$1,172,000 -96% 31 Mar 2023 10-K 29 May 2024 2024 FY
Q4 2022 $306,000 31 Dec 2022 10-Q 03 Feb 2023 2023 Q3
Q3 2022 $614,000 30 Sep 2022 10-Q 04 Nov 2022 2023 Q2
Q2 2022 $919,000 -$1,053,000 -53% 30 Jun 2022 10-Q 05 Aug 2022 2023 Q1
Q1 2022 $1,219,000 -$1,019,000 -46% 31 Mar 2022 10-K 22 May 2023 2023 FY
Q2 2021 $1,972,000 -$1,000,000 -34% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q1
Q1 2021 $2,238,000 +$2,238,000 31 Mar 2021 10-K 08 Jun 2022 2022 FY
Q4 2020 $2,392,000 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 $2,679,000 30 Sep 2020 10-Q 12 Nov 2020 2021 Q2
Q2 2020 $2,972,000 30 Jun 2020 10-Q 12 Aug 2020 2020 Q1
Q1 2020 $0 31 Mar 2020 10-K 01 Jun 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.